Search News + Media

Lung cancer is a leading cause of cancer death in the United States and worldwide – more than colon, breast and prostate cancer combined. Experts agree that lung cancer prevention for high-risk patients starts with lung cancer screening. In fact, studies show 20 percent fewer deaths among heavy smokers who were screened.

Sarah Persing, MD, MPH specializes in breast oncology, oncoplastic surgery, microsurgery and general plastic reconstructive surgeries at Tufts Medicine. She performs oncoplastic breast surgery at both Tufts Medical Center and MelroseWakefield Hospital and answers common questions about oncoplastic breast surgery.

Rutgers Cancer Institute of New Jersey and Tufts Medical Center Collaboration Published in Journal of Clinical Oncology.

A registered dietitian at Tufts Medical Center Cancer shares tips to boost your nutritional intake during chemotherapy.

National Cancer Institute Grant Awarded to Tufts Medical Center and Rutgers Cancer Institute of New Jersey Collaborators.

Prostate cancer is the most common cancer in American men and also the most common non-skin cancer among all Americans.

The Reid R. Sacco Adolescent & Young Adult (AYA) Cancer Program at Tufts Medical Center was created 7 years ago and the team has shared the creation and model of care in a recent publication.

Tufts Medical Center announced today that it has become the first center in New England to use the drug Jelmyto (UroGen Pharma, Inc.) for treatment of upper tract urothelial cancer (UTUC), a malignancy found in the kidney lining or the ureter, the thin tube connecting the bladder to the kidneys.

The financial impact of cancer, during treatment as well as during the years of long-term follow-up care, is experienced by many patients and survivors. AYAs may be further negatively impacted as they are historically the largest proportion of uninsured or underinsured patients.

Tufts Medical Center announced today that Rachel J. Buchsbaum, MD, has been named Director of the Cancer Center, effective August 12, 2019. Dr. Buchsbaum, a nationally-recognized physician, researcher, educator and leader in breast cancer therapy, risk assessment and prevention, will steer the cancer programs at Tufts MC.